Skip to Content
Get key facts and figures about chronic dry eye

Dexamethasone / neomycin ophthalmic Pregnancy and Breastfeeding Warnings

Dexamethasone / neomycin ophthalmic is also known as: AK-Neo-Dex, Neo-Decadron, Neo-Decadron Ocumeter, Neo-Dex, Neo-Dexair

Dexamethasone / neomycin ophthalmic Pregnancy Warnings

Dexamethasone-neomycin ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have shown corticosteroids to be teratogenic in mice and rabbits following multiple dose topical ophthalmic application. There are no controlled data in human pregnancy. Dexamethasone-neomycin ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.

See references

Dexamethasone / neomycin ophthalmic Breastfeeding Warnings

There are no data on the excretion of dexamethasone-neomycin ophthalmic into human milk. Topically applied steroids have been reported to be absorbed systemically. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. NeoDecadron (dexamethasone-neomycin ophthalmic)." Merck & Co, Inc, West Point, PA.

References for breastfeeding information

  1. "Product Information. NeoDecadron (dexamethasone-neomycin ophthalmic)." Merck & Co, Inc, West Point, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide